Author of the publication

Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial.

, , , , and . Clinical trials (London, England), 2 (5): 387-93 (January 2005)4845<m:linebreak></m:linebreak>LR: 20071115; GR: AG 03991/AG/NIA NIH HHS/United States; GR: AG 05681/AG/NIA NIH HHS/United States; JID: 101197451; ppublish;<m:linebreak></m:linebreak>Sample size; Comparacions múltiples.

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Extremal financial risk models and portfolio evaluation, and . Computational Statistics & Data Analysis, 51 (4): 2313--2338 (Dec 15, 2006)An Approximate Algorithm of Generating Variates and Computing Probabilities for Nonuniform Continuous Statistical Distributions., and . Simulation, 69 (2): 91-101 (1997)Advances in Econometrics. Volume 20, Part 2, chapter A New Class of Tail-dependent Time-Series Models and Its Applications in Financial Time Series, page 317--352. JAI, (2006)Hedging and Evaluating Tail Risks via Two Novel Options Based on Type II Extreme Value Distribution., , and . Symmetry, 13 (9): 1630 (2021)A peak-over-threshold search method for global optimization., , and . Autom., (2018)Image Fusion Method Based on Improved NSCT Transform and PCNN Model., , , , and . ISCID (1), page 28-31. IEEE, (2016)High-dimensional Clustering onto Hamiltonian Cycle., , , and . ICML, volume 202 of Proceedings of Machine Learning Research, page 13791-13813. PMLR, (2023)MEGATRON: Software-Managed Device TLB for Shared-Memory FPGA Virtualization., , , , , and . DAC, page 1213-1218. IEEE, (2021)Extreme co-movements and extreme impacts in high frequency data in finance, and . Journal of Banking & Finance, 31 (5): 1399--1415 (May 2007)Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial., , , , and . Clinical trials (London, England), 2 (5): 387-93 (January 2005)4845<m:linebreak></m:linebreak>LR: 20071115; GR: AG 03991/AG/NIA NIH HHS/United States; GR: AG 05681/AG/NIA NIH HHS/United States; JID: 101197451; ppublish;<m:linebreak></m:linebreak>Sample size; Comparacions múltiples.